Acute effect of Low Power Laser (red and infrared) on the performance of patients with peripheral arterial disease in the walk test: a randomized, double-blind, placebo-controlled trial

niversidade Estadual do Oeste do Paraná0 个研究点开始时间: 2022年9月12日最近更新: 2023年5月29日

适应症

试验速览

暂无简介。

•Diagnosis of Type 2 Diabetes Mellitus under treatment (presentation of a medical prescription containing the prescription of oral hypoglycemic agent and/or insulin); Both sexes; Between 45 and 75 years of age; Residence in the same city of the research

•Physical limitation (orthopedic, neurological or ophthalmic) to perform the physical tests (pain above 5 on the visual scale, disability or noticeable change in gait, amaurosis); Peripheral neuropathy from another cause (Hansen's disease, alcoholism or other); Symptomatic peripheral arterial disease (ankle-brachial index < 0.9 with interruption of any physical test due to claudicating pain); Painful ulcer anywhere on the lower limbs at the time of the first evaluation or during any stage of participation in the project; Amputation above the transmetatarsal; active plantar ulcer or use of implantable electrical device (contraindications for Bioimpedance); BMI = 40 kg/m2;
•Hospitalization in the 2 months prior to the start of the research, for any reason; COVID-19 diagnosed by examination: in the last 3 months (without hospitalization); within the last 6 months (with hospitalization without intubation) or any period prior to the survey (if intubated) or having post-COVID symptoms (regardless of the period of infection); Supervised physical exercise or treatment with electrical stimulation or phototherapy applied to the muscles of the lower limbs in the 6 months before the start of the research; Two absences from application sessions (consecutive or interspersed) while participating in the project.

发起方

niversidade Estadual do Oeste do Paraná